Amplitude Surgical (AMPLI) | Financial Analysis & Statements
Amplitude Surgical S.A.S. | Mid-cap | Healthcare
Amplitude Surgical S.A.S. | Mid-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
106.0M
Gross Profit
83.7M
78.93%
Operating Income
12.9M
12.17%
Net Income
1.5M
1.44%
Balance Sheet Metrics
Total Assets
279.3M
Total Liabilities
183.4M
Shareholders Equity
95.8M
Debt to Equity
1.91
Cash Flow Metrics
Operating Cash Flow
-5.3M
Free Cash Flow
-14.9M
Revenue & Profitability Trend
Amplitude Surgical Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 106.0M | 100.2M | 87.6M | 82.7M | 88.3M |
| Cost of Goods Sold | 22.3M | 21.2M | 20.3M | 19.0M | 22.7M |
| Gross Profit | 83.7M | 79.0M | 67.3M | 63.7M | 65.6M |
| Operating Expenses | 30.8M | 28.7M | 29.4M | 25.8M | 19.6M |
| Operating Income | 12.9M | 10.9M | 1.7M | -1.3M | -1.5M |
| Pre-tax Income | 1.6M | -6.0M | -1.6M | -11.5M | -11.3M |
| Income Tax | 92.0K | 769.0K | 1.2M | 1.9M | 3.3M |
| Net Income | 1.5M | 38.5M | -4.8M | -14.4M | -14.6M |
| EPS (Diluted) | - | €0.82 | -€0.09 | -€0.30 | -€0.30 |
Income Statement Trend
Amplitude Surgical Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 94.7M | 95.5M | 96.7M | 94.4M | 93.1M |
| Non-Current Assets | 184.6M | 170.6M | 162.8M | 174.6M | 182.1M |
| Total Assets | 279.3M | 266.0M | 259.5M | 269.1M | 275.2M |
| Liabilities | |||||
| Current Liabilities | 46.9M | 41.3M | 43.8M | 38.4M | 46.2M |
| Non-Current Liabilities | 136.5M | 128.9M | 163.1M | 173.8M | 158.1M |
| Total Liabilities | 183.4M | 170.2M | 206.9M | 212.2M | 204.3M |
| Equity | |||||
| Total Shareholders Equity | 95.8M | 95.8M | 52.6M | 56.9M | 70.9M |
Balance Sheet Composition
Amplitude Surgical Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.5M | 38.5M | -4.8M | -14.7M | -14.6M |
| Operating Cash Flow | -5.3M | 44.9M | -6.5M | -20.8M | -6.3M |
| Investing Activities | |||||
| Capital Expenditures | -10.4M | -11.2M | -5.2M | -5.1M | -5.1M |
| Investing Cash Flow | -12.1M | 53.7M | -5.7M | -5.1M | -4.9M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 2.5M | -37.4M | -5.5M | 3.4M | 14.3M |
| Free Cash Flow | -14.9M | -11.3M | -4.2M | -7.1M | 2.6M |
Cash Flow Trend
Amplitude Surgical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
307.50
Price to Book
3.12
Price to Sales
2.72
Profitability Ratios
Profit Margin
1.00%
Operating Margin
11.52%
Return on Equity
1.15%
Return on Assets
3.10%
Financial Health
Current Ratio
1.91
Debt to Equity
126.32
Beta
0.17
Per Share Data
EPS (TTM)
€0.02
Book Value per Share
€1.97
Revenue per Share
€2.26
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ampli | 295.0M | 307.50 | 3.12 | 1.15% | 1.00% | 126.32 |
| Crossject S.A | 80.5M | - | - | 478.68% | 0.00% | -7.88 |
| Visiomed Group SA | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
| Bonyf N.V | 8.2M | - | 18.85 | -38.97% | 8.54% | 0.00 |
| Spineway S.A | 3.9M | 0.02 | 0.07 | -17.85% | -30.35% | 7.50 |
| I.Ceram S.A | 155.7K | 9.88 | 0.46 | -124.00% | -170.02% | 476.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.